Report Details:
15 Companies Covered
108 Pages
According to a detailed study by Market Research Future (MRFR), the Global Ophthalmic Viscoelastic Devices Market size was estimated at USD 3.07 billion in 2024 and is projected to grow from USD 3.24 billion in 2025 to USD 5.53 billion by 2035, registering a compound annual growth rate (CAGR) of 5.50% during the forecast period (2025–2035).
The key players recognized by MRFR operating in the Ophthalmic Viscoelastic Devices Market include global healthcare leaders such as Ocular Therapeutix, Rayner Intraocular Lenses, Carl Zeiss AG, Alcon, and Hoya Corporation. The market is also supported by prominent industry participants, including Genzyme, Janssen Pharmaceuticals, Bausch Health, Johnson & Johnson, Santen Pharmaceutical, and Abbott Laboratories.
Market Highlights
The Ophthalmic Viscoelastic Devices Market is experiencing notable growth, driven by the increasing prevalence of eye diseases and a growing global aging population that creates higher demand for surgical procedures. The rise in cataract surgeries and other ophthalmic operations is contributing significantly to the market's expansion. Furthermore, technological advancements have led to the development of innovative viscoelastic devices that improve surgical outcomes, making procedures safer and more efficient.
Key market growth drivers include an increase in the geriatric population, rising prevalence of eye disorders like cataracts and glaucoma, growing awareness regarding eye health, and innovations in surgical techniques such as phacoemulsification. Additionally, manufacturers are heavily investing in research and development to introduce sustained-release formulations and biocompatible materials that enhance performance during eye surgeries. Strategic partnerships and collaborations among industry participants are also increasing to strengthen distribution networks and global market penetration.
Government regulations and supportive bodies are fostering growth through streamlined approval processes for ophthalmic devices. Initiatives aimed at expediting the approval of innovative products encourage manufacturers to invest in cutting-edge technologies. This supportive regulatory environment increases market competition and drives down costs, making advanced surgical solutions more accessible across expanding healthcare infrastructures.
Segment Analysis
The Global Ophthalmic Viscoelastic Devices Market is segmented by application, product type, end user, formulation type, and region.
Based on application, the market is segmented into Cataract Surgery, Corneal Surgery, Glaucoma Surgery, and Refractive Surgery. The Cataract Surgery segment dominates the market, valued at USD 0.9 billion in 2024 and projected to reach USD 1.5 billion by 2035 due to the high prevalence of cataracts among the aging population. Refractive Surgery is projected to grow from USD 0.65 billion in 2024 to USD 1.0 billion in 2035. Glaucoma Surgery is set to rise from USD 0.33 billion in 2024 to USD 0.55 billion by 2035, while Corneal Surgery is anticipated to grow from USD 0.25 billion in 2024 to USD 0.4 billion by 2035.
By product type, the market comprise into Hydrophobic, Hydrophilic, and Combination categories. Hydrophobic devices are widely favored in cataract surgeries for their cohesive properties that maintain anterior chamber stability. Hydrophilic devices offer superior hydration and easy application, while Combination products integrate both materials to provide versatile solutions for diverse surgical needs.
By end user, the market is divided into Hospitals, Ambulatory Surgical Centers, and Ophthalmic Clinics. Hospitals act as the primary setting for ophthalmic procedures, supporting a steady baseline demand. Ambulatory Surgical Centers are rapidly gaining prominence due to cost-effective solutions and shorter recovery times, while specialized Ophthalmic Clinics continue to drive adoption of advanced viscoelastic products.
Based on formulation type, the market is segmented into Single-Use and Multi-Use categories. Single-Use devices are witnessing a strategic market shift driven by infection control concerns and the demand for enhanced patient safety. Multi-Use formulations retain a presence in budget-conscious segments owing to their economic feasibility.
Regional Analysis
Regionally, the Global Ophthalmic Viscoelastic Devices Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
North America holds the majority market share, valued at USD 0.82 billion in 2024 and projected to reach USD 1.32 billion by 2035. This position is supported by advanced healthcare infrastructure, high demand for ophthalmic procedures, and strong local industry presence.
Europe holds the second-largest share, valued at USD 0.62 billion in 2024 and expected to reach USD 1.01 billion by 2035. Growth is driven by an aging population and increasing public awareness regarding eye health.
Asia-Pacific is projected to grow from USD 0.38 billion in 2024 to USD 0.61 billion by 2035. Rapid expansion is fueled by rising disposable incomes, expanding healthcare infrastructure, and an increasing volume of eye surgeries.
The Rest of the World segment, comprising regions such as the Middle East, Africa, and South America, is also showing gradual growth. The market in South America is expected to begin at USD 0.15 billion in 2024 and expand moderately to USD 0.25 billion by 2035, pointing to potential opportunities in this emerging market. Middle East and Africa is valued at USD 0.16 billion in 2024 and is expected to expand to USD 0.26 USD billion by 2035 as access to advanced healthcare technologies improves.
Key Findings of the Study
- The Global Ophthalmic Viscoelastic Devices Market size was valued at USD 3.07 billion in 2024 and is projected to reach USD 5.53 billion by 2035, growing at a 5.50% CAGR from 2025 to 2035.
- Cataract Surgery represents the largest application segment, valued at USD 0.9 billion in 2024 and expected to grow to USD 1.5 billion by 2035.
- Single-Use formulations are experiencing rapid growth due to heightened focus on infection control and cross-contamination prevention.
- Hospitals remain the primary end-user segment, while Ambulatory Surgical Centers are gaining popularity for cost-effective outpatient procedures.
- North America leads the global market with a USD 0.82 billion valuation in 2024, followed by Europe and Asia-Pacific.
- Key market participants include Ocular Therapeutix, Rayner Intraocular Lenses, Carl Zeiss AG, Alcon, Hoya Corporation, Genzyme, Janssen Pharmaceuticals, Bausch Health, Johnson & Johnson, Santen Pharmaceutical, and Abbott Laboratories.
Related Report:
https://www.marketresearchfuture.com/reports/ophthalmic-viscoelastic-devices-market-38830
